スポンサーリンク
メジカルビュー社 | 論文
- Effects of Extensive Reading on Medical Students' English Proficiency, Reading Strategies and Learning Strategies
- An application of the Consecutive Interpreting Approach to English for medical purposes (EMP)
- What's going on ゲノム MicroRNA expression profiles classify human cancers. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. Nature. 2005; 435: 834-8. PMID:
- What's going on 消化器癌 The role of UGT1A1*28 polymorphism in the pharmacodynamics and pharmacokinetics of irinotecan in patients with metastatic colorectal cancer. Toffoli G, et al. J Clin Oncol. 2006; 24: 3061-8. PMID: 16809730
- 60歳以上のDLBCL症例に対するR-CHOPとCHOPの第3相試験--導入療法後の奏功例に対してrituximab維持療法群と経過観察群に無作為化 (Hematology Symposium on Aggressive Lymphoma--Current Therapies for Aggressive Lymphoma in Japan,USA and Europe) -- (Session1 CHOP with or without Rituxan in previously untreated a
- マイクロアレイデータの評価 (特集 分子標的薬のSecond Wave) -- (PART3 評価のための臨床試験)
- CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.Coiffier B,et al.N Engl J Med 2002;346(4):235-42--CHOP+リツキシマブ併用療法は、CHOP療法を上回る治療法であり、DLBCLの治療動向に大きなimpactを与えた
- ガイドラインを日常臨床に活かすために 診療ガイドラインは癌医療に変革をもたらすか
- Trastuzumab(b)Trastuzumab臨床開発の現状と今後の展望 (特集 ADCCとCDCが飛躍的に高まった抗体療法)
- アントラサイクリン系薬剤の開発と今後の展望 (特集 化学療法の将来展望--抗癌剤-温故知新)
- What's going on 放射線 Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. Hartsell WF, et al. J Natl Cancer Inst. 2005; 97: 798-804. PMID: 15928300--有痛性骨転移に対する疼痛緩和目的の放射線治療において、1回照射と分割照射の同等性を無作為化比較試験で示した論文
- What's going on 造血器腫瘍 Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up. Czuczman MS, Weaver R, Alkuzweny B, Berlfein J, Grillo-Lopez
- What's going on 造血器腫瘍 Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone(CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with thera
- What's going on 進行乳癌患者の、緩和を目的とした化学療法の意思決定に関する論文[Grunfeld EA, Maher EJ, Browne S, Ward P, Young T, Vivat B, Walker G, Wilson C, Potts HW, Westcombe AM, Richards MA, Ramirez AJ'Advanced breast cancer patients' perceptions of decision making for palliative c
- 医療と通訳--コミュニケーションの視点から
- What's going on 婦人科癌 Randomized Phase 3 trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. Randall ME, Filiaci VL, Muss H, Spirtos NM, Mannel RS, Fowler
- What's going on 放射線 Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U. J Clin Oncol. 2005;23:5644-50. PMID:16110023. 直腸癌に
- 再発・再燃Aggressive B-cell Lymphomaに対するrituximabの検討--日本の多施設共同第2相試験および薬物動態研究 (Hematology Symposium on Aggressive Lymphoma--Current Therapies for Aggressive Lymphoma in Japan,USA and Europe) -- (Session1 CHOP with or without Rituxan in previously untreated aggr
- ファーマコゲノミクス、マーカー開発の最先端--診断と創薬の融合 (特集 分子標的薬のSecond Wave) -- (PART2 解明が進んだ予測因子)
- What's going on 構造化された多職種介入が進行がん患者のQOLに及ぼす影響を無作為化比較試験で示した論文[Rummans TA, Clark MM, Sloan JA, Frost MH, Bostwick JM, Atherton PJ, Johnson ME, Gamble G, Richardson J, Brown P, Martensen J, Miller J, Piderman K, Huschka M, Girardi J, Hanson J 'Impacting quali
スポンサーリンク